VAT Mass Test

Two people with the same weight, the same waist size, and the same BMI (body mass index, a height-and-weight ratio) can have wildly different health risks. The difference often lives in a place you cannot see or pinch: the fat packed deep around your liver, intestines, and other organs.

This deep fat, called VAT (visceral adipose tissue), behaves like an active organ. It pumps out inflammatory signals, reshapes how your body handles sugar, and tracks more closely with heart disease, diabetes, cancer, and early death than your overall fatness ever could.

What VAT Actually Is, and Why It Matters More Than Other Fat

Your body stores fat in two main places. Fat under your skin (subcutaneous fat) is what you can pinch on your thighs, hips, and belly. Visceral fat sits behind the abdominal wall, surrounding the organs. The two depots are not interchangeable. Visceral fat releases a steady stream of inflammatory molecules and hormones into the bloodstream, including signals that drive insulin resistance, raise blood pressure, and remodel blood vessels.

Studies that looked at the same people with imaging found that visceral fat is more strongly tied to high blood pressure, abnormal blood sugar, diabetes, and metabolic syndrome than fat under the skin, and the link holds even after accounting for BMI and waist size. In a Framingham Heart Study analysis with imaging on 3,001 adults, visceral fat tracked with metabolic risk in ways that subcutaneous fat did not. That is why two people with identical waists can sit on opposite ends of the risk spectrum.

Heart Disease and Stroke Risk

Visceral fat is one of the most consistent predictors of cardiovascular trouble across large studies. In a national Chinese cohort of 7,439 adults followed for seven years, the people in the top quarter of visceral adiposity had about 50% higher odds of cardiovascular disease and roughly 2.5 times the stroke risk compared with those in the bottom quarter, after adjusting for standard risk factors.

Genetic research strengthens the case for cause and effect. A Mendelian randomization analysis (a method that uses inherited genetic variation to test causality) found that genetically predicted visceral fat mass was tied to higher odds of coronary artery disease, heart attack, heart failure, and atrial fibrillation. In adults with prior premature coronary disease, those in the top third of visceral fat had about 2.7 times the rate of recurrent cardiovascular events over five years compared with the bottom third.

Sex matters in how this risk shows up. In Framingham, every standard-deviation increase in visceral fat in women was linked to substantially higher cardiovascular death risk, while waist and BMI captured most of the signal in men but missed it in women. Standard measurements often understate visceral fat risk in women specifically.

Type 2 Diabetes and Insulin Resistance

Visceral fat sits at the heart of insulin resistance, the condition in which your cells stop responding properly to insulin. In a study of 15,464 adults followed for up to 13 years, each one-unit rise in a visceral-fat composite score was linked to substantially higher diabetes risk after adjusting for lifestyle, blood pressure, lipids, and HbA1c (the three-month blood sugar average).

In a longitudinal imaging study of 1,106 adults, increases in abdominal fat over time tracked with new-onset high blood pressure, high triglycerides, and metabolic syndrome, even after adjusting for BMI and waist size. CT-measured visceral fat outperformed every other adiposity index for predicting insulin resistance across prediabetes subtypes in another study.

Cancer Risk

Visceral fat is linked to cancer in ways that total body fat is not. In a study of 4,364 adults followed for nearly 13 years, each standard-deviation increase in visceral fat was tied to higher cancer incidence and cancer mortality. The association persisted after adjusting for total fat mass, meaning visceral fat carries a cancer signal that overall body fat does not.

In the UK Biobank cohort of 385,477 adults followed for over eight years, the highest visceral fat group was tied to roughly double the risk of uterine cancer compared with the lowest, along with elevated risks for kidney, liver, gallbladder, colorectal, and breast cancer.

Kidney Disease, Gout, and Other Risks

In a Korean cohort of 11,050 adults followed for about 5.6 years, those in the top quarter of visceral fat had substantially higher risk of developing chronic kidney disease compared with the bottom quarter. The effect was strongest in normal-weight people with central obesity, who had about 2.3 times the kidney disease risk compared with normal-weight peers without it. This is the classic 'thin outside, fat inside' pattern that BMI alone misses.

Visceral fat is also tied to gout, sarcopenic obesity (muscle loss with fat gain), depression in vulnerable groups, female reproductive disorders including PCOS (polycystic ovary syndrome) and pre-eclampsia, and worse outcomes from COVID-19. Genetic analyses suggest the gout link is causal, with each standard-deviation increase in visceral fat tied to meaningfully higher gout risk.

Mortality

In the UK Biobank cohort followed for over 12 years, men in the top fifth of visceral fat had higher all-cause death risk compared with the middle, and women showed a similar though smaller pattern, after full adjustment for demographics, lifestyle, BMI, blood pressure, lipids, diabetes, and medications. In a separate analysis of 11,120 adults, each step up in a visceral-fat composite score was linked to higher all-cause, cardiovascular, and cancer mortality.

The mortality picture in older adults gets more nuanced. In adults over 65, the curve sometimes flattens or even reverses, with very low visceral fat associated with worse outcomes, likely because frailty and muscle loss become bigger threats than fat itself. The midlife window is where visceral fat appears to do the most damage.

Reference Ranges and What Counts as 'High'

There is no single universal cutoff for visceral fat. Thresholds vary by sex, ethnicity, age, body size, and the imaging method used (DXA scan versus CT versus MRI). The numbers below come from large research cohorts and should be treated as orientation, not a target. Your imaging center may report different numbers in different units, and you should compare your results within the same lab and method over time for the most meaningful trend.

Source: synthesized from the systematic review by Bennett and colleagues and standardization work across CT and DXA measurements. Sex-specific cutoffs are often lower in women. In Chinese adults, optimal visceral fat thresholds for metabolic syndrome were 210 cm² in men and 136 cm² in women. In an Algerian DXA cohort, mass-based thresholds for metabolic syndrome were 1,369 g in men and 1,082 g in women. Asian populations often show metabolic risk at lower visceral fat values than European populations, which matters for how you interpret your number.

What this means for you: a single number on a single scan does not tell the full story. Your visceral fat should be interpreted alongside your sex, ethnicity, age, blood pressure, blood sugar, lipids, and the specific imaging method used. A 'high' visceral fat reading paired with normal blood sugar and clean lipids is a different situation from the same reading paired with insulin resistance and rising triglycerides.

Why Your Trend Matters More Than Any Single Reading

DXA-based visceral fat measurements have meaningful variability, especially in leaner people. In a study of weight-stable adults, the within-person variability for visceral fat was higher than for other body compartments, and the precision was worst at low visceral fat values. The authors recommend interpreting changes only when visceral fat is above 500 g and BMI is at least 25 kg/m². In severely obese adults, changes smaller than about 0.8 kg may fall within normal scan-to-scan noise.

This is why a single reading is rarely actionable on its own. What matters is the trajectory: is your visceral fat creeping up year over year, holding steady, or coming down in response to changes you are making? A baseline scan, a follow-up in 3 to 6 months if you are actively making changes, and at least annual monitoring afterward give you a real picture of what is happening, not a snapshot pulled out of context. Track on the same machine when possible to minimize noise.

When Results Can Be Misleading

• Low visceral fat amounts: DXA scans of people with low visceral fat or BMI under 25 can produce unreliable readings and even occasional zero values. Trust changes more when your starting point is above 500 g.
• Hydration and recent meals: body composition scans are typically done fasted to standardize results. A scan done after a large meal or while heavily hydrated can shift readings.
• Different machines and methods: DXA, CT, and MRI all measure visceral fat slightly differently, and even different DXA models report different numbers. Switching machines mid-tracking can create artificial gaps or jumps.
• Sex and menopausal status: the metabolic meaning of a given visceral fat value differs between men and women, and shifts again after menopause, when visceral fat tends to rise even at stable weight.

What to Do If Your Visceral Fat Is High

A high reading is not a diagnosis on its own. It is a prompt to look at the surrounding picture. Order companion tests if you have not already: fasting insulin and HOMA-IR (a calculated insulin resistance score), HbA1c, a full lipid panel including ApoB (a count of harmful cholesterol-carrying particles), high-sensitivity CRP (a fine-tuned inflammation marker), liver enzymes including ALT (a liver enzyme), and uric acid. The pattern matters more than any single number.

If your visceral fat is high and your insulin, HbA1c, and triglycerides are also drifting, you are looking at metabolic syndrome territory and should act accordingly. If your visceral fat is high but your metabolic labs look clean, you have a window to intervene before they shift. Consider involving a metabolic health specialist or endocrinologist if your visceral fat is persistently elevated and your standard labs are also abnormal, especially if you have a family history of diabetes or early heart disease.